Starting from early adulthood, the maximum health attained during the first stages of life starts to decrease. Lifestyle and exposure to socioeconomic adversity may influence the rate of such a decline.
Existing and newly measured metabolomics, epigenomics and inflammatory markers will provide insightful information for the understanding of the biological pathways underlying healthy ageing processes.
One of the biggest societal challenges that Europe is facing is represented by the dramatic differentials in healthy ageing, quality of life and life expectancy between individuals of different socioeconomic groups. Understanding the determinants underlying these diverging health pathways is the main aim of the LIFEPATH project.